CONRIG PHARMA ApS: Financial statements 2012
CVR: 33373236
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
CONRIG PHARMA ApS (CVR 33373236) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -265,781 and a net result of DKK -243,991. Equity in the 2012 report amounted to DKK 199,626. The solvency ratio was 87%.
- Gross Profit
- DKK -265,781
- Profit/Loss
- DKK -243,991
- Equity
- DKK 199,626
- Total Assets
- DKK 229,542
Keep an eye on CONRIG PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of October 2, 2012, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of CONRIG PHARMA ApS.
As of October 2, 2012, EY Godkendt Revisionspartnerselskab has stepped down as auditor of CONRIG PHARMA ApS.
About CONRIG PHARMA ApS
CONRIG PHARMA ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Snickar Karl Johan Tobieson and Lars Christer Fredrik Fåhraeus. The company is owned by Melius Pharma AB. The company has 0 employees (2011). In 2025, the company reported a gross profit of DKK -98,936 and a net result of DKK -95,786 compared with DKK -100,217 the year before. Equity in the 2025 report amounted to DKK 0.